Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 782 of 6351
-
New pill targets Hard-to-Treat KRAS cancers in early human trial
Disease control Recruiting nowThis is a multicenter, open-label phase 1/2 study consisting of two parts: dose escalation phase and dose expansion phase. The objective of the dose escalation phase is to evaluate the safety, tolerability and pharmacokinetics of HYP-2090PTSA in patients with advanced solid tumor…
Phase 1/2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Glowing dye helps surgeons remove stomach cancer while saving healthy tissue
Disease control Recruiting nowThe main treatment for early gastric cancer (EGC) include endoscopic submucosal dissection (ESD) and radical gastrectomy. However, appropriate treatment for patients who exceed the absolute indications and noncurative resection of ESD remains unestablished. Sentinel node navigati…
Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Engineered immune cells take on lupus in first human test
Disease control OngoingThis is a Phase 1 study of obecabtagene autoleucel (obe-cel), autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19, to establish the tolerability, safety, preliminary efficacy, and pharmacokinetics of obe-cel in patients with severe, refractory SLE.
Phase 1 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a bronchial wash detect lung cancer mutations faster?
Diagnosis CompletedThe management of lung cancer is a major public health challenge. Molecular anomaly testing is recommended from the early stages for optimal and personalized care of all lung adenocarcinomas and non-smoker lung cancers. The search for these anomalies relies on increasingly advanc…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Can a diabetes drug shield kidney cells in Non-Diabetic kidney disease?
Disease control Recruiting nowPrimary Objective: To study podocyte specific injury markers in African American Veterans with non-diabetic kidney disease (NDKD), on empagliflozin therapy. Primary Endpoint: We will assess the effect of Empagliflozin on podocyte-specific proteins in exosomes isolated from subj…
Phase 4 • Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Radiation boost may extend life in advanced kidney cancer
Disease control Recruiting nowRenal cancer ranks seventh in incidence among men and sixth among women in the Beijing area, with Peking University First Hospital treating over 1,000 kidney cancer patients annually. Once recurrence or metastasis occurs, the prognosis is poor, with median progression times of 1-…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail aims to boost survival in colorectal cancer liver spread
Disease control Recruiting nowThe primary objective of this study is to assess whether the addition of Serplulimab (a PD-1 inhibitor) and Bevacizumab (an anti-angiogenesis agent) to the standard FOLFOX chemotherapy can enhance the immune microenvironment in the liver, increase T lymphocyte infiltration, and c…
Phase 2/3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Stem cell reset could open door to kidney transplants for 'Impossible' patients
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate whether a temporary reprogramming of the immune system can help highly sensitized (hyperimmunized) patients with end-stage kidney disease safely receive a compatible kidney transplant. Patients who are highly sensitized have deve…
Phase 1/2 • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
AI blood test could spot heart attacks faster
Diagnosis Recruiting nowThe goal of this observational study is to evaluate whether artificial intelligence (AI) algorithms can predict or exclude acute coronary syndrome (ACS) in adults using data generated by routine hematology testing. The main questions the study aims to answer are: * Can AI algori…
Sponsor: RobotDreams GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Scientists uncover hidden electrical switch that fuels colorectal Cancer's spread
Knowledge-focused CompletedSpatial heterogeneity represents a pivotal driver of therapeutic resistance and metastatic progression in colorectal cancer (CRC). However, the mechanical regulatory mechanisms governing intratumoral regional specialization remain incompletely understood. This study integrates sp…
Sponsor: Ma Tianyi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can fixing a varicocele beat antioxidants for boosting sperm?
Disease control CompletedPatient Information leaflet on varicoceles surgery
Sponsor: Sohag University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can sound and light waves calm the mind in schizophrenia?
Symptom relief CompletedThis randomized, sham-controlled trial evaluated the effects of 40-Hz binaural beat music (BBM) combined with 40-Hz rhythmic photic stimulation (RPS) in adults with schizophrenia spectrum disorders. A total of 55 participants with schizophrenia or schizoaffective disorder were ra…
Sponsor: National Cheng Kung University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can a Full-Body rehab program help children stop wetting?
Disease control CompletedUrinary incontinence is defined by the International Children's Continence Society as involuntary urinary leakage that can be continuous or intermittent in children aged five and over. Urinary incontinence is divided into subgroups of daytime incontinence, nocturnal enuresis and …
Sponsor: Damla Korkmaz Dayican • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New pill could tame tough psoriasis
Disease control OngoingThe purpose of the study is to see how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo and deucravacitinib.
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could IVF hormones trigger aging cells in the womb and lower pregnancy chances?
Knowledge-focused Recruiting nowBoth controlled ovarian stimulation (COS) and frozen embryo transfer has become an integral part of in vitro fertilization (IVF) treatment. Fresh embryo transfer is usually performed by providing Luteal Phase Support (LPS) with progesterone after COS. Frozen embryo transfer (FET)…
Sponsor: Fundación IVI • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Lung cancer drug adagrasib: which dose works best?
Disease control OngoingThis study will evaluate the efficacy of two dosing regimens of adagrasib (600 mg BID versus 400 mg BID) in patients with NSCLC with KRAS G12C mutation.
Phase 2 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Tailor-Made cancer therapies tested in unique N-of-1 trial
Disease control Recruiting nowThe purpose of this study is to collect data for assessing the improvement of the overall response rate for the overall cohorts and the proportion of patients accessing precision targeted therapy.
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a common ED drug help COPD patients breathe easier?
Disease control Recruiting nowERASE PH-COPD is a randomized double-blind study, with 2 parallel groups. Patients with severe pulmonary hypertension due to chronic obstructive pulmonary disease, will be randomly assigned to receive Tadalafil orally or placebo.
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New drug combo aims to shrink breast tumors before surgery
Disease control Recruiting nowThis study is a randomized, open-label, multicenter clinical study for patients with early or locally advanced (T≥2cm, N0-3, M0) HER2-positive breast cancer, aiming to compare the peripheral blood ctDNA clearance of neoadjuvant pyrotinib + trastuzumab + docetaxel and pertuzumab +…
Phase 2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Triple threat: immunotherapy and targeted drug join chemo to fight HER2+ gut cancers
Disease control Recruiting nowThe purpose of this study to find out whether adding trastuzumab and pembrolizumab to standard chemotherapy is an effective treatment for resectable HER2+ esophagogastric cancer.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC